Role of cytokines and chemokines in pseudomonal keratitis

Cornea

Volumn 24, Issue 8 SUPPL., 2005, Pages

  Matsumoto, Koki ^a   Ikema, Kousuke ^a   Tanihara, Hidenobu ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Chemokine; Inflammatory cytokine; Keratitis; Polymorphonuclear leukocyte; Pseudomonas aeruginosa

Indexed keywords

CHEMOATTRACTANT; CHEMOKINE; CYTOKINE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MACROPHAGE MIGRATION INHIBITION FACTOR; MATRIX METALLOPROTEINASE; MESSENGER RNA; PROTEIN BCL 2; PSEUDOMONAS EXOTOXIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TUMOR NECROSIS FACTOR ALPHA;

BACTERICIDAL ACTIVITY; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAM NEGATIVE INFECTION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; KERATITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 28044433678     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000178737.35297.d4     Document Type: Conference Paper

References (53)

1. Laibson PR. Annual review: cornea and sciera. Arch Ophthalmol. 1972; 88:553-574.
2. Laibson PR. Pseudomonas aeruginosa. In: Fraunfelder FT, Roy FH, eds. Current Ocular Therapy. Philadelphia: WB Saunders; 1990:35-43.
3. Tabbara KF, El-Sheikh HF, Aabed B. Extended wear contact lens related bacterial keratitis. Br J Ophthalmol. 2000;84:327-328.
4. Kernacki KA, Hobden JA, Hazlett LD, et al. In vivo bacterial protease production during Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 1995;36:1371-1378.
5. Kernacki KA, Fridman R, Hazlett LD, et al. In vivo characterization of host and bacterial protease expression during Pseudomonas aeruginosa corneal infections in naïve and immunized mice. Curr Eye Res. 1997;16: 289-297.
6. Matsumoto K. Role of bacterial proteases in pseudomonal and serratial keratitis. Biol Chem. 2004;385:1007-1016.
7. Matsumoto K, Shams NB, Hanninen LA, et al. Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. Invest Ophthalmol Vis Sci. 1993;34:1945-1953.
8. Matsumoto K, Shams NB, Hanninen LA, et al. Proteolytic activation of corneal matrix metalloproteinase by Pseudomonas aeruginosa elastase. Curr Eye Res. 1992;11:1105-1109.
9. Twining SS, Kirschner SE, Mahnke LA, et al. Effect of Pseudomonas aeruginosa elastase, alkaline protease, and exotoxin A on corneal proteinases and proteins. Invest Ophthalmol Vis Sci. 1993;34:2699-2712.
10. Miyajima S, Akaike T, Matsumoto K, et al. Matrix metalloproteinases induction by pseudomonal virulence factors and inflammatory cytokines in vitro. Microb Pathol. 2001;31:271-281.
11. Heck LW, Morihara K, Abrahamson DR. Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease. Infect Immun. 1986;54:149-153.
12. Heck LW, Morihara K, McRae WB, et al. Specific cleavage of human type III and IV collagens by Pseudomonas aeruginosa elastase. Infect Immun. 1986;51:115-118.
13. Steuhl KP, Doring G, Henni A, et al. Relevance of host-derived and bacterial factors in Pseudomonas aeruginosa corneal infections. Invest Ophthalmol Vis Sci. 1987;28:1559-1568.
14. Engel LS, Hill JM, Moreau JM, et al. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Invest Ophthalmol Vis Sci. 1998;39:662-665.
15. Chusid MJ, Davis SD. Experimental bacterial keratitis in neutropenic guinea pigs: polymorphonuclear leukocytes in corneal host defense. Infect Immun. 1979;24:948-952.
16. Thiel HJ, Steuhl KP, Doring G. Therapy of Pseudomonas aeruginosa eye infections. Antibiot Chemother. 1987;39:92-101.
17. + T cell-dependent keratitis with genetic susceptibility to Pseudomonas aeruginosa ocular infection. J Immunol. 1997;159:6283-6290.
18. Hazlett LD, McClellan S, Kwon B, et al. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive. Invest Ophthalmol Vis Sci. 2000;41:805-810.
19. Fleiszig SM, Zaidi TS, Fletcher EL, et al. Pseudomonas aeruginosa invades corneal epithelial cells during experimental infection. Infect Immun. 1994;62:3485-3493.
20. Fleiszig SM, Zaidi TS, Pier GB. Pseudomonas aeruginosa invasion of and multiplication within corneal epithelial cells in vitro. Infect Immun. 1995; 63:4072-4077.
21. Fleiszig SM, Zaidi TS, Preston MJ, et al. Relationship between cytotoxicity and corneal epithelial cell invasion by clinical isolates of Pseudomonas aeruginosa. Infect Immun. 1996;64:2288-2294.
22. Evans DJ, Frank DW, Finck-Barbancon V, et al. Pseudomonas aeruginosa invasion and cytotoxicity are independent events, both of which involve protein tyrosine kinase activity. Infect Immun. 1998;66:1453-1459.
23. Cole N, Willcox MD, Fleiszig SM, et al. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Curr Eye Res. 1998;17:730-735.
24. Lee EJ, Truong TN, Mendoza MN, et al. A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics. Curr Eye Res. 2003;27:289-299.
25. Holden BA, La Hood D, Grant T, et al. Gram-negative bacteria can induce contact lens related acute red eye (CLARE) responses. CLAO J. 1996;22: 47-52.
26. Cowell BA, Willcox MD, Hobden JA, et al. An ocular strain of Pseudomonas aeruginosa is inflammatory but not virulent in the scarified mouse model. Exp Eye Res. 1998;67:347-356.
27. Willcox MD, Hume EB. Differences in the pathogenesis of bacteria isolated from contact-lens-induced infiltrative conditions. Aust N Z J Ophthalmol. 1999;27:231-233.
28. Estrellas PS Jr, Alionte LG, Hobden JA. A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient. Curr Eye Res. 2000;20:157-165.
29. Xue ML, Thakur A, Willcox M. Gene expression of pro-inflammatory cytokines and chemokines in mouse eye infected with Pseudomonas aeruginosa. Clin Exp Ophthalmol. 2002;30:196-199.
30. Xue ML, Thakur A, Lutze-Mann L, et al. Pro-inflammatory cytokine/chemokine gene expression in human corneal epithelial cells colonized by Pseudomonas aeruginosa. Clin Exp Ophthalmol. 2000;28:197-200.
31. Thakur A, Xue M, Stapleton F, et al. Balance of pro- and anti-inflammatory cytokines correlates with outcome of acute experimental Pseudomonas aeruginosa keratitis. Infect Immun. 2002;70:2187-2197.
32. Dinarello CA, Wolff SM. The role of interleukin-1 in disease. N Engl J Med. 1993;328:106-113.
33. Rudner XL, Kernacki KA, Barrett RP, et al. Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation. J Immunol. 2000;164:6576-6582.
34. Xue ML, Zhu H, Willcox M, et al. The role of IL-1β in the regulation of IL-8 and IL-6 in human corneal epithelial cells during Pseudomonas aeruginosa colonization. Curr Eye Res. 2001;23:406-414.
35. Ries C, Petrides PE. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler. 1995;376:345-355.
36. Girard MT, Matsubara M, Fini ME, Transforming growth factor-β and interleukin-1 modulate metalloproteinase expression by corneal stromal cells. Invest Ophthalmol Vis Sci. 1991;32:2441-2454.
37. Xue ML, Wakefield D, Willcox MD, et al. Regulation of MMPs and TIMPs by IL-1β during corneal ulceration and infection. Invest Ophthalmol Vis Sci. 2003;44:2020-2025.
38. Thakur A, Barrett RP, McClellan S, et al. Regulation of Pseudomonas aeruginosa corneal infection in IL-1β converting enzyme (ICE, caspase-1) deficient mice. Curr Eye Res. 2004;29:225-233.
39. Thakur A, Barrett RP, Hobden JA, et al. Caspase-1 inhibitor reduces severity of Pseudomonas aeruginosa keratitis in mice. Invest Ophthalmol Vis Sci. 2004;45:3177-3184.
40. Xue ML, Zhu H, Thakur A, et al. 1α, 25-Dihydroxyvitamin D3 inhibits pro-inflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa. Immunol Cell Biol. 2002;80:340-345.
41. Cole N, Bao S, Willcox M, et al. Expression of interleukin-6 in the cornea in response to infection with different strains of Pseudomonas aeruginosa. Infect Immun. 1999;67:2497-2502.
42. Cole N, Bao S, Stapleton F, et al. Pseudomonas aeruginosa keratitis in IL-6-deficient mice. Int Arch Allergy Immunol. 2003;130:165-172.
43. Cole N, Krockenberger M, Bao S, et al. Effects of exogenous interleukin-6 during Pseudomonas aeruginosa corneal infection. Infect Immun. 2001; 69:4116-4119.
44. Kernacki KA, Barrett RP, Hobden JA, et al. Macrophage inflammatory protein-2 is a mediator of polymorphonuclear neutrophil influx in ocular bacterial infection. J Immunol. 2000;164:1037-1045.
45. Xue ML, Thakur A, Willcox MD, et al. Role and regulation of CXC-chemokines in acute experimental keratitis. Exp Eye Res. 2003;76:221-231.
46. Thakur A, Xue ML, Wang W, et al. Expression of macrophage migration inhibitory factor during Pseudomonas keratitis. Clin Exp Ophthalmol. 2001;29:179-182.
47. Cole N, Krockenberger M, Stapleton F, et al. Experimental Pseudomonas aeruginosa keratitis in interleukin-10 gene knockout mice. Infect Immun. 2003;71:1328-1336.
48. Hazlett LD, Rudner XL, McClellan SA, et al. Role of IL-12 and IFN-γ in Pseudomonas aeruginosa corneal infection. Invest Ophthalmol Vis Sci. 2002;43:419-424.
49. Hazlett LD, Huang X, McClellan SA, et al. Further studies on the role of IL-12 in Pseudomonas aeruginosa corneal infection. Eye. 2003;17:863-871.
50. Huang X, McClellan SA, Barrett RP, et al. IL-18 contributes to host resistance against infection with Pseudomonas aeruginosa through induction of IFN-γ production. J Immunol. 2002;168:5756-5763.
51. Huang X, Hazlett LD. Analysis of Pseudomonas aeruginosa corneal infection using an oligonucleotide microarray. Invest Ophthalmol Vis Sci. 2003;44:3409-3416.
52. Hazlett LD. Pathogenic mechanisms of P. aeruginosa keratitis: a review of the role of T cells, Langerhans cells, PMN, and cytokines. DNA Cell Biol. 2002;21:383-390,
53. Hazlett LD. Corneal response to Pseudomonas aeruginosa infection. Prog Retin Eye Res. 2004;23:1-30.